Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach
Randomized Control Study on Surgical Treatment for Middle and Lower Thoracic Esophageal Cancer Patients Without Upper Mediastinal Lymph Node Metastasis Through Left Versus Right Transthoracic Approach
Sponsor: Chinese Academy of Medical Sciences
A PHASE3 clinical study on Esophageal Cancer, this trial is ongoing. The trial is conducted by Chinese Academy of Medical Sciences and has accumulated 10 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Jan 2025 — Present [monthly]
Unknown PHASE3
-
Sep 2024 — Jan 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Dec 2022 — Oct 2023 [monthly]
Unknown Status PHASE3
▶ Show 5 earlier versions
-
Nov 2022 — Dec 2022 [monthly]
Unknown Status PHASE3
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status PHASE3
-
Jan 2020 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2020 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Academy of Medical Sciences
- Harbin Medical University
- Hebei Medical University Fourth Hospital
- Henan Cancer Hospital
- Hunan Cancer Hospital
- Liaoning Cancer Hospital & Institute
- Peking University Cancer Hospital & Institute
- Sun Yat-sen University
- Tongji Hospital
- Zhejiang Cancer Hospital
For direct contact, visit the study record on ClinicalTrials.gov .